AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 50 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $18,927,000 | +20.6% | 1,344,245 | +0.7% | 0.01% | +25.0% |
| Q4 2017 | $15,695,000 | -16.2% | 1,334,607 | +1.1% | 0.01% | -11.1% |
| Q3 2017 | $18,734,000 | +0.9% | 1,320,245 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $18,576,000 | -15.7% | 1,320,245 | 0.0% | 0.01% | -18.2% |
| Q1 2017 | $22,035,000 | -4.1% | 1,320,245 | -5.2% | 0.01% | -8.3% |
| Q4 2016 | $22,986,000 | +20.2% | 1,392,245 | -2.8% | 0.01% | +20.0% |
| Q3 2016 | $19,128,000 | +131.9% | 1,431,745 | +14.9% | 0.01% | +150.0% |
| Q2 2016 | $8,248,000 | -24.9% | 1,245,945 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $10,989,000 | -24.0% | 1,245,945 | +7.6% | 0.01% | -14.3% |
| Q4 2015 | $14,456,000 | -7.2% | 1,158,345 | +4.6% | 0.01% | -12.5% |
| Q3 2015 | $15,576,000 | +269.7% | 1,107,045 | +82.4% | 0.01% | +300.0% |
| Q2 2015 | $4,213,000 | -16.6% | 607,045 | +3.1% | 0.00% | 0.0% |
| Q1 2015 | $5,053,000 | +14.4% | 588,945 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $4,417,000 | +8.4% | 588,945 | -3.7% | 0.00% | 0.0% |
| Q3 2014 | $4,073,000 | -39.1% | 611,495 | -14.3% | 0.00% | -33.3% |
| Q2 2014 | $6,687,000 | -12.9% | 713,645 | +18.3% | 0.00% | -25.0% |
| Q1 2014 | $7,681,000 | – | 603,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|